BioSpace News Archive

Bolstering Its Presence in Lake County, Illinois

S1 Biopharma, Inc. (S1) announced today that researchers will present an expanded analysis of data from the company’s Phase 2a clinical trial of Lorexys™ for the treatment of women with hypoactive sexual desire disorder (HSDD) based on the Patient Global Impression of Change (PGIC) scale

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that in order to ensure optimal outcomes for patients, unrestricted sales and use of the Nellix System will cease immediately, and the product will only be available for use under clinical protocol with pre-screened patients that adhere to the current indications.

Technavio analysts forecast the global impetigo market to grow at a CAGR of 7% during the forecast period, according to their latest market research report.

Jenny Craig is featured in PEOPLE’s “Half Their Size” issue, on newsstands nationwide

Cerus Corporation (Nasdaq:CERS) announced today the appointment of William Moore to the newly created position of Senior Vice President of Manufacturing Operations and Supply Chain for Cerus, effective January 1, 2019.

Awards Further Establish Digipath as a Premier Testing Laboratory

Proteus Digital Health announced that Andy Thompson, Founder and Chief Executive Officer, will present an overview and update on Proteus Digital Health and digital medicines at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California

Phase II monotherapy study of bemcentinib in high-risk MDS & AML

Company also promotes Xiaoxiang Chen, MD, to Chief Development Officer, and Mai-Jing Liao, Ph.D., MBA to Chief Business Officer